Be yourself; Everyone else is already taken.
— Oscar Wilde.
This is the first post on my new blog. I’m just getting this new blog going, so stay tuned for more. Subscribe below to get notified when I post new updates.
Bad Injuries Connected to Zantac®
Due to results from Lab testing, the U.S. FDA has learned that Zantac® and various ranitidine medications contain a nitrosamine issue called N–nitrosodimethylamine (NDMA) at low concentrations. NDMA is classified as a probable human carcinogen – a substance that could cause cancer in humans. NDMA is a known environmental contaminant and found in water and food sources, including meats, dairy items, and vegetables.
What is NDMA?
N–nitrosodimethylamine (NDMA) is classified as a probable human carcinogen which means that it is more probable than not to cause cancer in humans. NDMA has been researched in animal populations and found to increase the occurrence of cancer in the animals. The studies have raised the chance of an association between NDMA and liver toxicity that can continue to the development of liver cancer and other related conditions created from an NDMA–induced reaction to the liver.
The amount and length of human NDMA exposure which can lead to the development of cancer is not precisely known. Also, zantac recall and duration of the NDMA contamination of Zantac® and various ranitidine medicines are not precisely understood.
Issues Associated with Exposure to NDMA
NDMA has been studied in animal populations and determined to increase the happening of cancer in the animals. Based on these studies, the US EPA classifies NDMA as a probable human carcinogen. The research has raised the probability of a connection between NDMA and liver toxicity which may lead to the development of liver cancer and other associated issues due to an NDMA injury to the liver. Some have suggested that NDMA may also be linked to other cancers such as:
Bladder Cancer, Esophageal Cancer, Kidney Cancer, Non–Hodgkin’s Lymphoma.
Have Other Ranitidine Products Also Been Affected?
Yes. The U.S. Food and Drug Administration has alerted health care professionals and consumers to three existing voluntary recalls of ranitidine.
Perrigo Company plc has voluntarily recalled over–the–counter (OTC) ranitidine tablets due to the potential of N–Nitrosodimethylamine (NDMA) in the medication.
Novitium Pharma LLC has voluntarily recalled all unexpired quantities and lots of ranitidine hydrochloride medication due to the possibility of NDMA in the medication.
Lannett Company, Inc. has voluntarily recalled all unexpired lots of prescription ranitidine syrup due to the presence of NDMA found in the drug.
Should I Stop Taking Zantac® or Other Ranitidine Medicines?
On October 28, 2019, the FDA advised patients and consumers taking Zantac® and other ranitidine medications as follows:
“Patients taking prescription ranitidine who wish to stop should talk to their health care professional about other treatment options. Consumers taking OTC ranitidine, which is used to prevent and relieve heartburn associated with acid indigestion and sour stomach, may consider using other OTC products approved for their condition. FDA’s testing of samples of alternatives such as Pepcid (famotidine), Tagamet (cimetidine), Nexium (esomeprazole), Prevacid (lansoprazole), and Prilosec (omeprazole) show no NDMA in these medicines.”
Consultation
Meneo Law Group is a leading consumer law firm for the recovery of damages because of to NDMA injury. Feel free to contact us at any time to discuss your injury and potential for recovery.
What is NDMA?
N–nitrosodimethylamine (NDMA) is classified as a probable human carcinogen which means that it is more probable than not to cause cancer in humans. NDMA has been researched in animal populations and found to increase the occurrence of cancer in the animals. The studies have raised the chance of an association between NDMA and liver toxicity that can continue to the development of liver cancer and other related conditions created from an NDMA–induced reaction to the liver.
The amount and length of human NDMA exposure which can lead to the development of cancer is not precisely known. Also, zantac recall and duration of the NDMA contamination of Zantac® and various ranitidine medicines are not precisely understood.
Issues Associated with Exposure to NDMA
NDMA has been studied in animal populations and determined to increase the happening of cancer in the animals. Based on these studies, the US EPA classifies NDMA as a probable human carcinogen. The research has raised the probability of a connection between NDMA and liver toxicity which may lead to the development of liver cancer and other associated issues due to an NDMA injury to the liver. Some have suggested that NDMA may also be linked to other cancers such as:
Bladder Cancer, Esophageal Cancer, Kidney Cancer, Non–Hodgkin’s Lymphoma.
Have Other Ranitidine Products Also Been Affected?
Yes. The U.S. Food and Drug Administration has alerted health care professionals and consumers to three existing voluntary recalls of ranitidine.
Perrigo Company plc has voluntarily recalled over–the–counter (OTC) ranitidine tablets due to the potential of N–Nitrosodimethylamine (NDMA) in the medication.
Novitium Pharma LLC has voluntarily recalled all unexpired quantities and lots of ranitidine hydrochloride medication due to the possibility of NDMA in the medication.
Lannett Company, Inc. has voluntarily recalled all unexpired lots of prescription ranitidine syrup due to the presence of NDMA found in the drug.
Should I Stop Taking Zantac® or Other Ranitidine Medicines?
On October 28, 2019, the FDA advised patients and consumers taking Zantac® and other ranitidine medications as follows:
“Patients taking prescription ranitidine who wish to stop should talk to their health care professional about other treatment options. Consumers taking OTC ranitidine, which is used to prevent and relieve heartburn associated with acid indigestion and sour stomach, may consider using other OTC products approved for their condition. FDA’s testing of samples of alternatives such as Pepcid (famotidine), Tagamet (cimetidine), Nexium (esomeprazole), Prevacid (lansoprazole), and Prilosec (omeprazole) show no NDMA in these medicines.”
Consultation
Meneo Law Group is a leading consumer law firm for the recovery of damages because of to NDMA injury. Feel free to contact us at any time to discuss your injury and potential for recovery.
Serious Injuries Attributed to Zantac®
Based on results of Lab testing, the Food and Drug Administration has learned that Zantac® and other ranitidine based medications have a nitrosamine impurity called N–nitrosodimethylamine (NDMA) at lower concentrations. NDMA is thought of as a probable human carcinogen – a substance might cause cancer in humans. NDMA is a classified environmental contaminant and found in water and foods, including meats, dairy products, and vegetables.
What is NDMA?
N–nitrosodimethylamine (NDMA) is known as a likely human carcinogen that means that it’s more likely than not to cause cancer in humans. NDMA has been researched in animal populations and observed to increase the creation of cancer in the animals. The research has raised the chance of an connection between NDMA and liver toxicity which may continue to the development of liver cancer and various connected conditions brought about by an NDMA–induced treatment of the liver.
The amount and duration of human NDMA exposure that may lead to the development of cancer is not exactly known. Similarly, the amount and duration of the NDMA contamination of Zantac® and various ranitidine medications are not exactly known.
Diseases Associated with Exposure to NDMA
NDMA has been studied in animal populations and found to increase the occurrence of cancer in the animals. In light of these studies, the US EPA classifies NDMA as a likely human carcinogen. The studies have increased the probability of a connection between NDMA and liver toxicity which can lead to the creation of liver cancer and various associated issues brought about by an NDMA injury to the liver. Others have claimed that NDMA could also be linked to other cancers such as:
Bladder Cancer, Colorectal Cancer, Prostate Cancer, Non–Hodgkin’s Lymphoma.
Has Other Ranitidine Products Also Been Affected?
Yes. The U.S. Food and Drug Administration has informed health care professionals and consumers to three existing voluntary recalls of ranitidine.
Perrigo Company plc has voluntarily recalled over–the–counter (OTC) ranitidine tablets because of the possibility of N–Nitrosodimethylamine (NDMA) in the medicine.
Novitium Pharma LLC has voluntarily recalled all unexpired amounts and lots of ranitidine hydrochloride capsules due to the potential of NDMA in the medicine.
Lannett Company, Inc. has voluntarily recalled all unexpired lots of prescription ranitidine syrup due to the presence of NDMA found in the drug.
Should I Stop Taking Zantac® or Other Ranitidine Medications?
On zantac lawsuit , 2019, the FDA advised patients and consumers taking Zantac® and other ranitidine medicines as follows:
“Patients taking prescription ranitidine who wish to stop should talk to their health care professional about other treatment options. Consumers taking OTC ranitidine, which is used to prevent and relieve heartburn associated with acid indigestion and sour stomach, may consider using other OTC products approved for their condition. FDA’s testing of samples of alternatives such as Pepcid (famotidine), Tagamet (cimetidine), Nexium (esomeprazole), Prevacid (lansoprazole), and Prilosec (omeprazole) show no NDMA in these medicines.”
Consultation
Meneo Law Group is a leading consumer advocate for the recovery of damages because of to NDMA injury. Feel free to reach out at any time to explore your injury and potential for recovery.
What is NDMA?
N–nitrosodimethylamine (NDMA) is known as a likely human carcinogen that means that it’s more likely than not to cause cancer in humans. NDMA has been researched in animal populations and observed to increase the creation of cancer in the animals. The research has raised the chance of an connection between NDMA and liver toxicity which may continue to the development of liver cancer and various connected conditions brought about by an NDMA–induced treatment of the liver.
The amount and duration of human NDMA exposure that may lead to the development of cancer is not exactly known. Similarly, the amount and duration of the NDMA contamination of Zantac® and various ranitidine medications are not exactly known.
Diseases Associated with Exposure to NDMA
NDMA has been studied in animal populations and found to increase the occurrence of cancer in the animals. In light of these studies, the US EPA classifies NDMA as a likely human carcinogen. The studies have increased the probability of a connection between NDMA and liver toxicity which can lead to the creation of liver cancer and various associated issues brought about by an NDMA injury to the liver. Others have claimed that NDMA could also be linked to other cancers such as:
Bladder Cancer, Colorectal Cancer, Prostate Cancer, Non–Hodgkin’s Lymphoma.
Has Other Ranitidine Products Also Been Affected?
Yes. The U.S. Food and Drug Administration has informed health care professionals and consumers to three existing voluntary recalls of ranitidine.
Perrigo Company plc has voluntarily recalled over–the–counter (OTC) ranitidine tablets because of the possibility of N–Nitrosodimethylamine (NDMA) in the medicine.
Novitium Pharma LLC has voluntarily recalled all unexpired amounts and lots of ranitidine hydrochloride capsules due to the potential of NDMA in the medicine.
Lannett Company, Inc. has voluntarily recalled all unexpired lots of prescription ranitidine syrup due to the presence of NDMA found in the drug.
Should I Stop Taking Zantac® or Other Ranitidine Medications?
On zantac lawsuit , 2019, the FDA advised patients and consumers taking Zantac® and other ranitidine medicines as follows:
“Patients taking prescription ranitidine who wish to stop should talk to their health care professional about other treatment options. Consumers taking OTC ranitidine, which is used to prevent and relieve heartburn associated with acid indigestion and sour stomach, may consider using other OTC products approved for their condition. FDA’s testing of samples of alternatives such as Pepcid (famotidine), Tagamet (cimetidine), Nexium (esomeprazole), Prevacid (lansoprazole), and Prilosec (omeprazole) show no NDMA in these medicines.”
Consultation
Meneo Law Group is a leading consumer advocate for the recovery of damages because of to NDMA injury. Feel free to reach out at any time to explore your injury and potential for recovery.
Introduce Yourself (Example Post)
This is an example post, originally published as part of Blogging University. Enroll in one of our ten programs, and start your blog right.
You’re going to publish a post today. Don’t worry about how your blog looks. Don’t worry if you haven’t given it a name yet, or you’re feeling overwhelmed. Just click the “New Post” button, and tell us why you’re here.
Why do this?
- Because it gives new readers context. What are you about? Why should they read your blog?
- Because it will help you focus you own ideas about your blog and what you’d like to do with it.
The post can be short or long, a personal intro to your life or a bloggy mission statement, a manifesto for the future or a simple outline of your the types of things you hope to publish.
To help you get started, here are a few questions:
- Why are you blogging publicly, rather than keeping a personal journal?
- What topics do you think you’ll write about?
- Who would you love to connect with via your blog?
- If you blog successfully throughout the next year, what would you hope to have accomplished?
You’re not locked into any of this; one of the wonderful things about blogs is how they constantly evolve as we learn, grow, and interact with one another — but it’s good to know where and why you started, and articulating your goals may just give you a few other post ideas.
Can’t think how to get started? Just write the first thing that pops into your head. Anne Lamott, author of a book on writing we love, says that you need to give yourself permission to write a “crappy first draft”. Anne makes a great point — just start writing, and worry about editing it later.
When you’re ready to publish, give your post three to five tags that describe your blog’s focus — writing, photography, fiction, parenting, food, cars, movies, sports, whatever. These tags will help others who care about your topics find you in the Reader. Make sure one of the tags is “zerotohero,” so other new bloggers can find you, too.
The Love of Holck 306 